3
Registered trials
3
Recruiting
3
Unique sponsors
5
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
3
Mechanism of action (INN-stem analysis)
Unknown / small molecule
4 substances
Taxane
1 substance
Phase II:
2
Phase I (First in Human):
1
Phase II
2 trials-
RecruitingNovartis Pharma AG Commercial177LU-FAP-2286; CALCIUM FOLINATE; FAP-2286; PACLITAXEL ALBUMIN-BOUND
-
RecruitingUniversitaetsklinikum Ulm AöR AcademicIMP not specified
Phase I (First in Human)
1 trial-
RecruitingBioNTech SE CommercialBNT329
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Novartis Pharma AG | Commercial | 1 | Phase II | 1 |
| BioNTech SE | Commercial | 1 | Phase I (First in Human) | 1 |
| Universitaetsklinikum Ulm AöR | Academic | 1 | Phase II | 1 |
New trials by year
2025
2
2026
1